Elevated level of acetylation of APE1 in tumor cells modulates DNA damage repair

Shiladitya Sengupta, Anil K. Mantha, Heyu Song, Shrabasti Roychoudhury, Somsubhra Nath, Sutapa Ray, Kishor K Bhakat

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Apurinic/apyrimidinic (AP) sites are frequently generated in the genome by spontaneous depurination/depyrimidination or after removal of oxidized/modified bases by DNA glycosylases during the base excision repair (BER) pathway. Unrepaired AP sites are mutagenic and block DNA replication and transcription. The primary enzyme to repair AP sites in mammalian cells is AP endonuclease (APE1), which plays a key role in this repair pathway. Although overexpression of APE1 in diverse cancer types and its association with chemotherapeutic resistance are well documented, alteration of posttranslational modification of APE1 and modulation of its functions during tumorigenesis are largely unknown. Here, we show that both classical histone deacetylase HDAC1 and NAD+-dependent deacetylase SIRT1 regulate acetylation level of APE1 and acetylation of APE1 enhances its AP-endonuclease activity both in vitro and in cells. Modulation of APE1 acetylation level in cells alters AP site repair capacity of the cell extracts in vitro. Primary tumor tissues of diverse cancer types have higher level of acetylated APE1 (AcAPE1) compared to adjacent non-tumor tissue and exhibit enhanced AP site repair capacity. Importantly, in the absence of APE1 acetylation, cells accumulate AP sites in the genome and show increased sensitivity to DNA damaging agents. Together, our study demonstrates that elevation of acetylation level of APE1 in tumor could be a novel mechanism by which cells handle the elevated levels of DNA damages in response to genotoxic stress and maintain sustained proliferation.

Original languageEnglish (US)
Pages (from-to)75197-75209
Number of pages13
JournalOncotarget
Volume7
Issue number46
DOIs
StatePublished - Jan 1 2016

Fingerprint

Acetylation
DNA Repair
DNA Damage
Endonucleases
Neoplasms
Histone Deacetylase 1
Genome
DNA Glycosylases
Post Translational Protein Processing
Cell Extracts
DNA Replication
NAD
Carcinogenesis
DNA
Enzymes
In Vitro Techniques

Keywords

  • Acetylation
  • Apurinic/apyrimidinic endonuclease 1 (APE1)
  • BER
  • DNA damage repair

ASJC Scopus subject areas

  • Oncology

Cite this

Elevated level of acetylation of APE1 in tumor cells modulates DNA damage repair. / Sengupta, Shiladitya; Mantha, Anil K.; Song, Heyu; Roychoudhury, Shrabasti; Nath, Somsubhra; Ray, Sutapa; Bhakat, Kishor K.

In: Oncotarget, Vol. 7, No. 46, 01.01.2016, p. 75197-75209.

Research output: Contribution to journalArticle

Sengupta, S, Mantha, AK, Song, H, Roychoudhury, S, Nath, S, Ray, S & Bhakat, KK 2016, 'Elevated level of acetylation of APE1 in tumor cells modulates DNA damage repair', Oncotarget, vol. 7, no. 46, pp. 75197-75209. https://doi.org/10.18632/oncotarget.12113
Sengupta S, Mantha AK, Song H, Roychoudhury S, Nath S, Ray S et al. Elevated level of acetylation of APE1 in tumor cells modulates DNA damage repair. Oncotarget. 2016 Jan 1;7(46):75197-75209. https://doi.org/10.18632/oncotarget.12113
Sengupta, Shiladitya ; Mantha, Anil K. ; Song, Heyu ; Roychoudhury, Shrabasti ; Nath, Somsubhra ; Ray, Sutapa ; Bhakat, Kishor K. / Elevated level of acetylation of APE1 in tumor cells modulates DNA damage repair. In: Oncotarget. 2016 ; Vol. 7, No. 46. pp. 75197-75209.
@article{a8c26bca53304543ab15b23fde07c5d7,
title = "Elevated level of acetylation of APE1 in tumor cells modulates DNA damage repair",
abstract = "Apurinic/apyrimidinic (AP) sites are frequently generated in the genome by spontaneous depurination/depyrimidination or after removal of oxidized/modified bases by DNA glycosylases during the base excision repair (BER) pathway. Unrepaired AP sites are mutagenic and block DNA replication and transcription. The primary enzyme to repair AP sites in mammalian cells is AP endonuclease (APE1), which plays a key role in this repair pathway. Although overexpression of APE1 in diverse cancer types and its association with chemotherapeutic resistance are well documented, alteration of posttranslational modification of APE1 and modulation of its functions during tumorigenesis are largely unknown. Here, we show that both classical histone deacetylase HDAC1 and NAD+-dependent deacetylase SIRT1 regulate acetylation level of APE1 and acetylation of APE1 enhances its AP-endonuclease activity both in vitro and in cells. Modulation of APE1 acetylation level in cells alters AP site repair capacity of the cell extracts in vitro. Primary tumor tissues of diverse cancer types have higher level of acetylated APE1 (AcAPE1) compared to adjacent non-tumor tissue and exhibit enhanced AP site repair capacity. Importantly, in the absence of APE1 acetylation, cells accumulate AP sites in the genome and show increased sensitivity to DNA damaging agents. Together, our study demonstrates that elevation of acetylation level of APE1 in tumor could be a novel mechanism by which cells handle the elevated levels of DNA damages in response to genotoxic stress and maintain sustained proliferation.",
keywords = "Acetylation, Apurinic/apyrimidinic endonuclease 1 (APE1), BER, DNA damage repair",
author = "Shiladitya Sengupta and Mantha, {Anil K.} and Heyu Song and Shrabasti Roychoudhury and Somsubhra Nath and Sutapa Ray and Bhakat, {Kishor K}",
year = "2016",
month = "1",
day = "1",
doi = "10.18632/oncotarget.12113",
language = "English (US)",
volume = "7",
pages = "75197--75209",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "46",

}

TY - JOUR

T1 - Elevated level of acetylation of APE1 in tumor cells modulates DNA damage repair

AU - Sengupta, Shiladitya

AU - Mantha, Anil K.

AU - Song, Heyu

AU - Roychoudhury, Shrabasti

AU - Nath, Somsubhra

AU - Ray, Sutapa

AU - Bhakat, Kishor K

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Apurinic/apyrimidinic (AP) sites are frequently generated in the genome by spontaneous depurination/depyrimidination or after removal of oxidized/modified bases by DNA glycosylases during the base excision repair (BER) pathway. Unrepaired AP sites are mutagenic and block DNA replication and transcription. The primary enzyme to repair AP sites in mammalian cells is AP endonuclease (APE1), which plays a key role in this repair pathway. Although overexpression of APE1 in diverse cancer types and its association with chemotherapeutic resistance are well documented, alteration of posttranslational modification of APE1 and modulation of its functions during tumorigenesis are largely unknown. Here, we show that both classical histone deacetylase HDAC1 and NAD+-dependent deacetylase SIRT1 regulate acetylation level of APE1 and acetylation of APE1 enhances its AP-endonuclease activity both in vitro and in cells. Modulation of APE1 acetylation level in cells alters AP site repair capacity of the cell extracts in vitro. Primary tumor tissues of diverse cancer types have higher level of acetylated APE1 (AcAPE1) compared to adjacent non-tumor tissue and exhibit enhanced AP site repair capacity. Importantly, in the absence of APE1 acetylation, cells accumulate AP sites in the genome and show increased sensitivity to DNA damaging agents. Together, our study demonstrates that elevation of acetylation level of APE1 in tumor could be a novel mechanism by which cells handle the elevated levels of DNA damages in response to genotoxic stress and maintain sustained proliferation.

AB - Apurinic/apyrimidinic (AP) sites are frequently generated in the genome by spontaneous depurination/depyrimidination or after removal of oxidized/modified bases by DNA glycosylases during the base excision repair (BER) pathway. Unrepaired AP sites are mutagenic and block DNA replication and transcription. The primary enzyme to repair AP sites in mammalian cells is AP endonuclease (APE1), which plays a key role in this repair pathway. Although overexpression of APE1 in diverse cancer types and its association with chemotherapeutic resistance are well documented, alteration of posttranslational modification of APE1 and modulation of its functions during tumorigenesis are largely unknown. Here, we show that both classical histone deacetylase HDAC1 and NAD+-dependent deacetylase SIRT1 regulate acetylation level of APE1 and acetylation of APE1 enhances its AP-endonuclease activity both in vitro and in cells. Modulation of APE1 acetylation level in cells alters AP site repair capacity of the cell extracts in vitro. Primary tumor tissues of diverse cancer types have higher level of acetylated APE1 (AcAPE1) compared to adjacent non-tumor tissue and exhibit enhanced AP site repair capacity. Importantly, in the absence of APE1 acetylation, cells accumulate AP sites in the genome and show increased sensitivity to DNA damaging agents. Together, our study demonstrates that elevation of acetylation level of APE1 in tumor could be a novel mechanism by which cells handle the elevated levels of DNA damages in response to genotoxic stress and maintain sustained proliferation.

KW - Acetylation

KW - Apurinic/apyrimidinic endonuclease 1 (APE1)

KW - BER

KW - DNA damage repair

UR - http://www.scopus.com/inward/record.url?scp=84996743350&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84996743350&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.12113

DO - 10.18632/oncotarget.12113

M3 - Article

C2 - 27655688

AN - SCOPUS:84996743350

VL - 7

SP - 75197

EP - 75209

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 46

ER -